Ratings by Jones Trading (Debanjana Chatterjee)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/4/2026 | Intellia Therapeutics | NTLA | Upgrade | Buy (Hold) |
13.60 (13.44) |
-1.18% | Details | |
| 3/2/2026 | Opus Genetics | IRD | Maintain | Buy (N/A) |
|
Details | ||
| 1/5/2026 | Armata Pharmaceuticals | ARMP | New Coverage | Buy (N/A) |
6.56 (10.60) |
61.59% | Details | |
| 12/1/2025 | Spyre | SYRE | Upgrade | Buy (Hold) |
29.75 (40.15) |
34.96% | Details | |
| 11/28/2025 | Absci Corp. | ABSI | Maintain | Buy (N/A) |
|
Details | ||
| 11/21/2025 | Contineum Therapeutics | CTNM | Maintain | Buy (N/A) |
|
Details | ||
| 11/18/2025 | Theravance Biopharma | TBPH | Maintain | Buy (N/A) |
|
Details | ||
| 11/11/2025 | Intellia Therapeutics | NTLA | Downgrade | Hold (Buy) |
9.73 (13.60) |
39.77% | Details | |
| 9/8/2025 | Sionna Therapeutics | SION | New Coverage | Buy (N/A) |
24.00 (35.93) |
49.71% | Details | |
| 8/18/2025 | Opus Genetics | IRD | Maintain | Buy (N/A) |
|
Details | ||
| 8/18/2025 | Tvardi Therapeutics Inc | TVRD | Maintain | Buy (N/A) |
|
Details | ||
| 8/18/2025 | Sagimet Biosciences Inc | SGMT | Maintain | Buy (N/A) |
|
Details | ||
| 8/15/2025 | Theravance Biopharma | TBPH | Maintain | Buy (N/A) |
|
Details | ||
| 7/17/2025 | Kalvista Pharmaceuticals Inc | KALV | Maintain | Buy (N/A) |
|
Details | ||
| 7/17/2025 | Clearside Biomedical | CLSD | Downgrade | Hold (Buy) |
0.84 (0.41) |
-51.19% | Details | |
| 6/16/2025 | Theravance Biopharma | TBPH | New Coverage | Buy (N/A) |
10.69 (13.57) |
26.94% | Details | |
| 4/28/2025 | Tvardi Therapeutics Inc | TVRD | New Coverage | Buy (N/A) |
18.85 (3.93) |
-79.15% | Details | |
| 3/13/2025 | Contineum Therapeutics | CTNM | New Coverage | (N/A) |
7.56 (13.88) |
83.6% | Details | |
| 1/27/2025 | Sagimet Biosciences Inc | SGMT | New Coverage | Buy (N/A) |
4.20 (5.41) |
28.81% | Details | |
| 12/11/2024 | Spyre | SYRE | New Coverage | Hold (N/A) |
26.81 (29.75) |
10.97% | Details | |
| 12/4/2024 | Absci Corp. | ABSI | New Coverage | Buy (N/A) |
3.15 (2.38) |
-24.44% | Details | |
| 9/27/2024 | Kalvista Pharmaceuticals Inc | KALV | New Coverage | Buy (N/A) |
10.00 (16.23) |
62.3% | Details | |
| 9/19/2024 | Pharvaris B.V. | PHVS | New Coverage | Buy (N/A) |
20.26 (25.91) |
27.89% | Details | |
| 9/17/2024 | Intellia Therapeutics | NTLA | New Coverage | Buy (N/A) |
21.51 (13.44) |
-37.52% | Details | |
| 8/27/2024 | Clearside Biomedical | CLSD | Maintain | Buy (N/A) |
|
Details | ||
| 8/7/2024 | Clearside Biomedical | CLSD | New Coverage | Buy (N/A) |
1.09 (0.84) |
-22.94% | Details | |
| 8/7/2024 | EyePoint Pharmaceuticals, Inc. | EYPT | New Coverage | Buy (N/A) |
8.60 (15.75) |
83.14% | Details |
